Related Experiment Video

Updated: Apr 19, 2026

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
08:31

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

883

TKIs may be option for Ph-like ALL

    Cancer Discovery
    |December 6, 2014
    PubMed

    Abstract:

    A recently identified subtype of acute lymphoblastic leukemia called Ph-like ALL is driven by an assortment of genetic changes that activate kinase signaling--alterations that may be vulnerable to FDA-approved tyrosine kinase inhibitors.

    More Related Videos

    Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
    10:49

    Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

    Published on: September 18, 2013

    18.8K
    Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
    07:38

    Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

    Published on: June 6, 2025

    957

    Related Experiment Videos

    Last Updated: Apr 19, 2026

    Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
    08:31

    Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

    Published on: October 17, 2025

    883
    Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
    10:49

    Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

    Published on: September 18, 2013

    18.8K
    Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
    07:38

    Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

    Published on: June 6, 2025

    957

    Related Concept Videos

    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    9.2K
    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against...
    9.2K

    Articles linked to this work by shared authors, journal, and citation graph.

    AI Model Predicts Cancer Development, Diagnoses Tumors.

    Cancer discovery·2026

    In Regulatory First, Myeloma Drug Approved Based on MRD Negativity.

    Cancer discovery·2026

    Transmissible Cancer Discovered in Catfish.

    Cancer discovery·2026

    Follicular Lymphoma Transformation is Characterized by Cytokine-associated Remodeling of Stromal and Macrophage Compartments.

    Cancer discovery·2026

    Genomics of Subsequent Neoplasms in Childhood Cancer Survivors.

    Cancer discovery·2026

    A Counterintuitive Approach to Cancer Therapy.

    Cancer discovery·2026

    PML-driven sumoylation of PML::RARA-bound repressors drives hematopoietic progenitor immortalization.

    The Journal of experimental medicine·2026

    Blood-test monitoring strategies for patients established on immune-suppressing drugs: a mixed-methods study.

    Health technology assessment (Winchester, England)·2026

    Evaluation of the Biological Activity of Echinococcus granulosus Hydatid Cyst Antigens on HRT-18 Colorectal Cancer Cells: Cytotoxicity and DNA Damage.

    Asian Pacific journal of cancer prevention : APJCP·2026

    Potential pitfalls in diagnostic and therapeutic decision-making in pulmonary embolism-related obstructive shock in patients with cancer: a case report.

    European heart journal. Case reports·2026

    Acromegaly Discovered After Head Trauma: Multivessel Coronary Disease and Postoperative Meningitis Complicating a Pituitary Macroadenoma.

    Cureus·2026

    A Rare Presentation of Metastatic Extragonadal Nonseminomatous Germ Cell Tumor Complicated by Suspected Transfusion-Associated Circulatory Overload.

    Cureus·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us